Navigation Links
Face, Facial Lipoatrophy With Radiesse, FDA Certifies

Rockville-The Food and Drug Administration has given the go-ahead to the new cosmetic filler, Radiesse, to treat chronic facial lipoatrophy, otherwise called fat loss,// occurring in patients with AIDS or HIV. This calcium based treatment, is found to assist in the manufacture of collagen.

To ascertain the potential benefits of this filler, FDA embarked on a study of 100 HIV patients suffering facial lipoatrophy. The patients were given a shot of Radiesse and re-examined after six months. The evaluation revealed that 78% of the patients needed minimal fine tuning, yet not more than three injections.

The only side-effects which showed up were short-term inflammation, pain and reddening of the skin.
'"/>




Page: 1

Related medicine news :

1. Smoke - At the Risk of Your Face, Skin and Health
2. Early Detection Of Facial Abnormalities in a Fetus
3. Children With Facial Anomalies Are Affected By Parental Tensions
4. Autism childrens lack Facial response
5. The Looming Controversy Surrounding Facial Transplant
6. The Brain behind Facial Recognition
7. A New Bioactive Cement For Facial Reconstruction the future
8. A Chinese Hunter on the Road to Recovery after a Facial Transplant
9. Study Finds That Migraine Drug Can Ease The Severest Of Facial Pain
10. Study Offers Hope In Prevention Of Facial Paralysis
11. Chronic Facial Pain Tackled By Cortex Stimulation
Post Your Comments:
Breaking Medicine News(10 mins):Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 2Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 3Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 4Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 5Health News:BHR Pharma Files Investigational New Drug Application, Receives Orphan Drug Designation, for Traumatic Brain Injury Treatment 2Health News:The Breema Center Presents a Yearlong Campaign to Transform Stress into Harmony in 2010 and Beyond 2Health News:LCA-Vision Joins Forces With the Wounded Warrior Project to Give the Gift of Enhanced Vision to Wounded American Heroes 2Health News:Anesiva Stockholders Approved Merger With Arcion Therapeutics but Merger Remains Contingent on Other Closing Conditions 2Health News:Anesiva Stockholders Approved Merger With Arcion Therapeutics but Merger Remains Contingent on Other Closing Conditions 3
Breaking Medicine Technology:ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer 2Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 2Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 3Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 4Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 5Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R) 2Warner Chilcott to Present at the Goldman Sachs 30th Annual Healthcare Conference 48171 1Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 1Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 2Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 3New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 1New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 2New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 3New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 4